Listen Live
St. Jude Radiothon 2024
CLOSE

via BlackDoctor:

Although multiple sclerosis (MS) is more likely to be diagnosed in adults between the ages of 20 and 40, children can also develop the autoimmune disease. According to a recent study, between 8,000 and 10,000 children under the age of 18 are diagnosed with MS each year, and many more could be living with the condition but have yet to be diagnosed.

Researchers say the first drug for children with MS vastly outperformed another common MS medication in a new clinical trial. Fingolimod (Gilenya) reduced relapse rates by 82 percent in patients aged 10 to 17 compared with interferon beta-1a, a drug commonly used to slow the progression of the degenerative nerve disease.

Nearly 86 percent of children on fingolimod remained relapse-free after two years of treatment, compared with only 39 percent of children taking interferon beta-1a, researchers reported.

CLICK HERE to read story

Leave a Reply